With the availability of drugs for ADHD and Alzheimer disease, more and more healthy people who have no mental health condition have been asking their psychiatrist to prescribe neuroenhancing medications in the hopes of improving their memory, cognitive focus, or attention span.
What's an appropriate response when one of your patients asks for a prescription for a drug for this off-label purpose?
The ethical issues that surround such requests are the subject of a study recently published in the journal Neurology. And it is that paper that Dr. Cynthia Geppert has chosen as her "Top Paper of the Year." In the next few minutes, Dr. Geppert will discuss the highlights of that study—and will tell you how she thinks the results could affect your clinical practice.
|Dr Geppert's Top Paper of the Year: When a Patient Asks You For a Neuroenhancer|
Dr Geppert's Top Paper of the Year: When a Patient Asks You For a Neuroenhancer
|Subscribe to our podcasts|
Read the abstract of the original Neurology article here:
Responding to requests from adult patients for neuroenhancements